# Kanchufang

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kanchufang

- Industry: Healthcare IT
- Headquarters: Shanghai, China
- Website: www.kanchufang.com
- Total disclosed funding: $5M
- Latest round: Series A (Sep 1, 2014)
- Investors on record: 2

## About

Kanchufang is a technology-driven healthcare company that specializes in AI-powered diagnostics and telemedicine solutions to improve patient care and clinical outcomes across various medical fields.Kanchufang, founded in 2013 in Shanghai, China, provides innovative healthcare solutions through AI technology. The company underwent a Series A funding round in September 2014, raising USD 5 mn from major investors including Sequoia Capital and Lightspeed Venture Partners. With two deals completed, Kanchufang has focused on enhancing its services in healthcare diagnostics and telemedicine.Kanchufang offers advanced AI healthcare services that cover multiple medical specialties such as hematology, urology, oncology, and dermatology. The core products include AI-driven diagnostic tools and telemedicine services aimed at improving patient care and clinical effectiveness. These solutions cater to hospitals, clinics, and healthcare providers across Asia, Europe, and North America, addressing challenges in timely diagnosis and treatment management.Kanchufang's revenue model is based on B2B partnerships with healthcare institutions and direct sales of AI healthcare solutions. The company typically engages in subscription agreements for their diagnostic tools and telemedicine platforms, which may feature tiered pricing based on usage scale. Collaborations with hospitals and clinics also lead to integrated service offerings, facilitating recurring revenue through ongoing agreements.Following the Series A funding of USD 5 mn in September 2014, Kanchufang aims to expand its product offerings and enhance market reach. Plans include the development of new healthcare diagnostic tools and expanding services into new geographic regions beyond current markets in Asia, Europe, and North America. The funding will support these initiatives and the company is focused on leveraging its AI technology to streamline healthcare delivery.

## Funding rounds

- Series A, Sep 1, 2014, $5M — Lightspeed Venture Partners, Hong Shan

## Investors

- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series A
- Hong Shan — Series A